FDA MedWatch Safety Information
Dec. 3, 2009

Audience: Neurological and Obstetrical healthcare professionals

The FDA notified health care professionals and patients about the increased risk of neural tube defects and other major birth defects, such as craniofacial defects and cardiovascular malformations, in babies exposed to valproate sodium and related products (valproic acid and divalproex sodium) during pregnancy. Healthcare practitioners should inform women of childbearing potential about these risks, and consider alternative therapies, especially if using valproate to treat migraines or other conditions not usually considered life-threatening.

Read entire article:  http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm192788.htm

« Return to news items

News Feed

Related Posts

• Paxil and Prozac Linked to Risk of Heart Birth Defects (0)
• Update of Swedish Study Upholds Concern for Antidepressant Induced Birth Defects (0)
• Antidepressant Drugs Are Not Safe During Pregnancy—No Matter What the Pharma Shills Say (1)
• New Study—Psychiatric Drugs Cause Birth Defects— pregnant women warned about smoking/alcohol but not psychiatric drugs (0)
• Medscape – Psychotropic Medications Linked to Serious Adverse Drug Reactions in Children (4)

Tags: bipolar, birth defects, divalproex sodium, Pregnancy, valproate sodium, valproic acid

This entry was posted on Thursday, December 3rd, 2009 at 4:48 pm and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.